APA (7th ed.) Citation

Boeckmans, J., Gatzios, A., Schattenberg, J. M., Rodrigues, R. M., Rogiers, V., & Vanhaecke, T. (2023). Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: Missed chances and future opportunities. Archives of Toxicology, 97(6), 1825. https://doi.org/10.1007/s00204-023-03498-0

Chicago Style (17th ed.) Citation

Boeckmans, Joost, Alexandra Gatzios, Jörn M. Schattenberg, Robim M. Rodrigues, Vera Rogiers, and Tamara Vanhaecke. "Pharmacogenetics in Early Drug Development for Non-alcoholic Steatohepatitis: Missed Chances and Future Opportunities." Archives of Toxicology 97, no. 6 (2023): 1825. https://doi.org/10.1007/s00204-023-03498-0.

MLA (9th ed.) Citation

Boeckmans, Joost, et al. "Pharmacogenetics in Early Drug Development for Non-alcoholic Steatohepatitis: Missed Chances and Future Opportunities." Archives of Toxicology, vol. 97, no. 6, 2023, p. 1825, https://doi.org/10.1007/s00204-023-03498-0.